Gori, Stefania <br/><br/>
Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.  [electronic resource] 

 -  The oncologist  Jul 2007 
 - 766-73 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1083-7159 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.12-7-766  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Central Nervous System Neoplasms--drug therapy<br/>Disease Progression<br/>Female<br/>Genes, erbB-2--drug effects<br/>Humans<br/>Incidence<br/>Middle Aged<br/>Neoplasm Metastasis--drug therapy<br/>Regression Analysis<br/>Retrospective Studies<br/>Risk Factors<br/>Survival Analysis<br/>Trastuzumab<br/>Treatment Outcome